- Home
- KRMD vs VERU Comparison
KRMD vs VERU Comparison
Compare KRMD & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- VERU
- Stock Information
- Founded
- KRMD 1980
- VERU 1971
- Country
- KRMD United States
- VERU United States
- Employees
- KRMD N/A
- VERU N/A
- Industry
- KRMD Medical/Dental Instruments
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- VERU Health Care
- Exchange
- KRMD Nasdaq
- VERU Nasdaq
- Market Cap
- KRMD 187.5M
- VERU 75.1M
- IPO Year
- KRMD N/A
- VERU 1990
- Fundamental
- Price
- KRMD $2.98
- VERU $0.50
- Analyst Decision
- KRMD Strong Buy
- VERU Strong Buy
- Analyst Count
- KRMD 5
- VERU 4
- Target Price
- KRMD $4.70
- VERU $4.00
- AVG Volume (30 Days)
- KRMD 179.6K
- VERU 2.1M
- Earning Date
- KRMD 04-30-2025
- VERU 02-13-2025
- Dividend Yield
- KRMD N/A
- VERU N/A
- EPS Growth
- KRMD N/A
- VERU N/A
- EPS
- KRMD N/A
- VERU N/A
- Revenue
- KRMD $31,993,796.00
- VERU $16,886,419.00
- Revenue This Year
- KRMD $20.53
- VERU N/A
- Revenue Next Year
- KRMD $13.94
- VERU $30.16
- P/E Ratio
- KRMD N/A
- VERU N/A
- Revenue Growth
- KRMD 11.57
- VERU 22.46
- 52 Week Low
- KRMD $2.04
- VERU $0.48
- 52 Week High
- KRMD $5.05
- VERU $1.92
- Technical
- Relative Strength Index (RSI)
- KRMD 22.69
- VERU 39.89
- Support Level
- KRMD $3.16
- VERU $0.49
- Resistance Level
- KRMD $4.83
- VERU $0.62
- Average True Range (ATR)
- KRMD 0.17
- VERU 0.04
- MACD
- KRMD -0.08
- VERU 0.00
- Stochastic Oscillator
- KRMD 2.52
- VERU 14.29
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.